Template:Chemical SUIT-034 NADH mt D082: Difference between revisions
From Bioblast
(Created page with "{| class="wikitable" border="1" {{Template:Chemicals header}} |- | 1D.1 | {{Template:ADP}} | |- | 2PGM | {{Template:Pyruvate}}, {{Template:Glutamate}}, and {{Template:Malate...") |
No edit summary |
||
| Line 11: | Line 11: | ||
| | | | ||
|- | |- | ||
| | | 3D2.5 | ||
| {{Template:ADP}} | | {{Template:ADP}} | ||
| | | | ||
|- | |- | ||
| | | 4U | ||
| {{Template:SF6847}} | | {{Template:SF6847}} | ||
| | | We do not recommend the use of any other uncoupler, like {{Template:CCCP}}, due to background fluorescence. | ||
|- | |- | ||
| | | 5Anox | ||
| | |||
| The O<sub>2</sub> concentration in the O2k-chamber can be decreased by N<sub>2</sub> or H<sub>2</sub> injection to reach faster anoxia, see: [[Setting the oxygen concentration]]. | |||
|- | |||
| 6Myx | |||
| {{Template:Myxothiazol}} | | {{Template:Myxothiazol}} | ||
| We do not recommend the use of any other inhibitor of complex III, like {{Template:Antimycin A}}, due to background fluorescence. | |||
|- | |||
| 7Reox | |||
| | |||
| | | | ||
|} | |} | ||
Revision as of 12:57, 14 December 2023
| Step | Chemical(s) and link(s) | Comments |
|---|---|---|
| 1D.1 | ADP (D) | |
| 2PGM | Pyruvate (P), Glutamate (G), and Malate (M) | |
| 3D2.5 | ADP (D) | |
| 4U | SF6847 | We do not recommend the use of any other uncoupler, like Carbonyl cyanide m-chlorophenyl hydrazone, CCCP (U), due to background fluorescence. |
| 5Anox | The O2 concentration in the O2k-chamber can be decreased by N2 or H2 injection to reach faster anoxia, see: Setting the oxygen concentration. | |
| 6Myx | Myxothiazol | We do not recommend the use of any other inhibitor of complex III, like Antimycin A (Ama), due to background fluorescence. |
| 7Reox |
